To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
State Retirement Pensions: Women
Thursday 14th November 2024

Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire)

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, with reference to the report by the Parliamentary and Health Service Ombudsman entitled Women’s State Pension age: our findings on injustice and associated issues, published on 21 March 2024, whether compensation proposals will form part of a future fiscal event.

Answered by Emma Reynolds - Parliamentary Secretary (HM Treasury)

I was the first Minister in 8 years to meet the WASPI campaign group and listen to their concerns.

We need time to review and consider the Ombudsman’s report along with the evidence provided during the investigation.

Once this work has been undertaken, the Government will be in a position to outline its approach.

Division Vote (Commons)
13 Nov 2024 - Exiting the European Union - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and in line with the House
One of 57 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 412 Noes - 16
Division Vote (Commons)
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and against the House
One of 65 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 93 Noes - 355
Division Vote (Commons)
12 Nov 2024 - House of Lords (Hereditary Peers) Bill - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and in line with the House
One of 65 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 435 Noes - 73
Division Vote (Commons)
6 Nov 2024 - Budget Resolutions - View Vote Context
Susan Murray (LD) voted No - in line with the party majority and against the House
One of 59 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 371 Noes - 77
Division Vote (Commons)
6 Nov 2024 - Budget Resolutions - View Vote Context
Susan Murray (LD) voted No - in line with the party majority and against the House
One of 62 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes
Vote Tally: Ayes - 383 Noes - 184
Division Vote (Commons)
6 Nov 2024 - Budget Resolutions - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and in line with the House
One of 63 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 454 Noes - 124
Division Vote (Commons)
6 Nov 2024 - Budget Resolutions - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and in line with the House
One of 65 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 455 Noes - 125
Division Vote (Commons)
6 Nov 2024 - Budget Resolutions - View Vote Context
Susan Murray (LD) voted Aye - in line with the party majority and in line with the House
One of 64 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes
Vote Tally: Ayes - 450 Noes - 120
Written Question
NHS: Drugs
Tuesday 5th November 2024

Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that suitable stockpiles of essential medications are available to the NHS to limit the effects of production shortages.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Whilst stock of a small number of medicines is held by the Government, for example as a result of COVID-19 preparedness, stockpiling essential medicines centrally is not a tool that the Department uses to limit the effects of production shortages. While we can’t always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they do arise, to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, including pharmacists, so they can advise and support their patients.